[Inflammatory polyneuropathies can be treated successfully].
Neurologiska kliniken, Karolinska universitetssjukhuset, Huddinge. rayomand.press@karolinska.se
Rayomand
R
Press
Håkan
H
Askmark
Oluf
O
Andersen
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001167:Arteritis / Q000628:therapy; D020274:Autoimmune Diseases of the Nervous System / Q000175:diagnosis / Q000628:therapy; D019091:Critical Pathways; D004185:Disability Evaluation; D020275:Guillain-Barre Syndrome / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007167:Immunotherapy; D016472:Motor Neuron Disease / Q000175:diagnosis / Q000628:therapy; D020364:Paraneoplastic Polyneuropathy / Q000175:diagnosis / Q000628:therapy; D010265:Paraproteinemias / Q000175:diagnosis / Q000628:therapy; D010523:Peripheral Nervous System Diseases / Q000175:diagnosis / Q000628:therapy; D011115:Polyneuropathies / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic